Monday, February 19, 2024

Marginalization, Denial and Censorship are NO ACCIDENT

 

During a Feb. 15 hearing by the Select Subcommittee on the Coronavirus Pandemic, Dr. Peter Marks FDA Director of the Center for Biologics Evaluation and Research avoided answering a direct question posed by the subcommittee regarding FDA's surveillance of the VAERS database for COVID-19 vaccine injuries. 

Given that the mRNA vaccines are a new technology first rolled out to the public during the COVID-19 pandemic, one would think that regulatory agencies would carefully monitor safety, particularly since these vaccines were "mandated" by the Biden Administration OSHA division and many corporations.

I know from personal experience how hazardous the mRNA technology can be, and I am truly outraged that evidence deemed negative is being ignored and/or censored (as "mal" or "dis" information) while criticism of the vaccines is literally being criminalized.

IGNORING EVIDENCE OF HARM

Dr. Marks referred the question about hazard surveillance to Dr. Daniel Jernigan, director of the National Center for Emerging and Zoonotic Infectious Diseases. Jernigan’s response not only lacks empirical support, but contradicts well documented research findings regarding mRNA vaccine risks:

Megan Redshaw 2/15/2024 Updated: 2/16/2024). US Officials Concede No Active Surveillance on Long-Term Effects of COVID-19 Vaccines. Epoch Times https://www.theepochtimes.com/health/us-officials-concede-no-active-surveillance-on-long-term-effects-of-covid-19-vaccines-5588199?utm_source=ref_share&utm_campaign=copy

“So with regard to myocarditis, we certainly have been monitoring the issue with various different data systems. I think the most recent data really demonstrates that you’re about eight times less likely to get myocarditis if you’re vaccinated compared to those that are unvaccinated,” Dr. Daniel Jernigan, director of the National Center for Emerging and Zoonotic Infectious Diseases at the CDC responded.

Apparently, Dr. Jernigan hasn’t read the following important study conducted in Israel that found myocarditis coincided with the vax rollouts, not the virus effects:

Sun, C.L.F., Jaffe, E. & Levi, R. Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave. Sci Rep 12, 6978 (2022). https://doi.org/10.1038/s41598-022-10928-z

Why would Dr. Jernigan state an uncertain finding of vaccine safety with such inappropriately exaggerated confidence and in so doing trivialize the well-documented risk of myocarditis in young men?

Note that he absolves responsibility for his assertion with the legal out of a faulty recollection through his “I think” caveat.

Notwithstanding his dissembling, what could be motivating this push to promote endless mRNA COVID-19 vaccine boosters and mRNA tech with no consideration of safety risks? What is going on here? Is this where we find ourselves?

Crutchfield P. Compulsory moral bioenhancement should be covert. Bioethics. 2019 Jan;33(1):112-121. doi: 10.1111/bioe.12496. Epub 2018 Aug 29. PMID: 30157295.

Or is the answer as simply as the reduction of human life into livestock for experimentation and exploitation?

DOCUMENTATION OF LACK OF TRANSPARENCY

"The C.D.C. Isn’t Publishing Large Portions of the Covid Data It Collects" The New York Times https://www.nytimes.com/2022/02/20/health/covid-cdc-data.html

SHUTTING DOWN INTERNAL DISSENT

Marty Makary April 3, 2022 FDA Shuts Out Its Own Experts in Authorizing Another Vaccine Booster. The Wall Street Journal, https://www.wsj.com/articles/fda-shuts-out-its-own-experts-in-authorizing-another-booster-covid-vaccine-pandemic-science-11649016728

Decisions like this only reinforce the perception that Covid policy is driven by groupthink and politics... Another committee member, Cody Meissner, agrees. Dr. Meissner, chief of pediatric infectious diseases at Tufts Children’s Hospital, told me last week that the fourth dose is “an unanswered scientific question for people with a normal immune system.” A third member of the committee, Paul Offit of the Children’s Hospital of Philadelphia, told the Atlantic that he advised his 20-something son to forgo the third shot, which the FDA recommends for everyone 12 and over. ... Two top FDA officials quit the agency in September complaining of undue pressure to authorize boosters. Marion Gruber, former director of the Office of Vaccine Research and Review, and her deputy, Philip Krause, later wrote about the lack of data to support a broad booster authorization. Hours after the FDA authorized the fourth dose, the Centers for Disease Control and Prevention gave its formal approval to the move—also without convening its external vaccine experts

AND then there are these articles, among others, voicing scientific and medical skepticism about the risk-benefit calculus being deployed by the FDA and WH:

Philip Krause and Luciana Borio March 28, 2022 You Likely Don’t Need a Fourth Covid Shot Unless you’re at high risk, the initial two vaccine doses are enough. The Wall Street Journal. https://www.wsj.com/articles/you-likely-dont-need-a-fourth-covid-shot-booster-dose-pfizer-moderna-vaccine-omicron-ba-2-ba2-11648498217

Dr. Krause is a consultant to the World Health Organization and was deputy director of FDA’s Office of Vaccines Research and Review, 2011-21. Dr. Borio is a senior fellow for global health at the Council on Foreign Relations and was director for medical and biodefense preparedness policy at the National Security Council, 2017-19

See also Constanze Kuhlmann, Carla Konstanze Mayer, Mathilda Claassen, Tongai Maponga, Wendy A Burgers,  Roanne Keeton, et al. (2022, January 18, 2022). Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose. The Lancet.DOI:https://doi.org/10.1016/S0140-6736(22)00090-3

IGNORING CONTRARY EVIDENCE

Israeli study shows 4th shot of COVID-19 vaccine not able to block Omicron. (2022, January 17). MSN.Com https://www.msn.com/en-us/news/world/israeli-study-shows-4th-shot-of-covid-19-vaccine-not-able-to-block-omicron/ar-AASRT8Q

Lock, S. (2022, January 11). Repeated Covid boosters not viable strategy against new variants, WHO experts warn. https://www.theguardian.com/world/2022/jan/12/repeated-covid-boosters-not-viable-strategy-against-new-variants-who-experts-warn

CENSORED

This study cited here was algorithmically censored in 2021. I know because my posted comments online with this doi (article locator number) were censored. Here is the citation and the link to the press release for your reference:

SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
Yuyang Lei , Jiao Zhang , Cara R. Schiavon, Ming He, Lili Chen, Hui Shen, Yichi Zhang, Qian Yin , Yoshitake Cho , Leonardo Andrade , Gerald S. Shadel , Mark Hepokoski, Ting Lei, Hongliang Wang, Jin hang, Jason X.-J. Yuan, Atul Malhotra, Uri Manor, Shengpeng Wang, Zu-Yi Yuan, John Y-J. Shyy Originally published31 Mar 2021https://doi.org/10.1161/CIRCRESAHA.121.318902Circulation Research. 2021;128:1323–1326

Other studies documented also that the spike protein, detached from the rest of the virus, elicits cell signalling in human cells, which "may promote pulmonary vacular remodeling and PAH [pulmonary arterial hypertension] as well as other cardiovascular complications":

Yuichiro J. Suzuki1,* and Sergiy G. Gychka SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines. Vaccines 2021, 9(1), 36; https://doi.org/10.3390/vaccines9010036
Here is an instructive excerpt from this research study:

3. SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Cells
It was found that the treatment of cultured primary human pulmonary artery smooth muscle cells (SMCs) or human pulmonary artery endothelial cells with the recombinant SARS-CoV-2 spike protein S1 subunit is sufficient to promote cell signaling without the rest of the viral components [21]. Furthermore, our analysis of the postmortem lung tissues of patients who died of COVID-19 has determined that these patients exhibited pulmonary vascular wall thickening, a hallmark of pulmonary arterial hypertension (PAH) [21]. Based on these results, we proposed that the SARS-CoV-2 spike protein (without the rest of the viral components) triggers cell signaling events that may promote pulmonary vascular remodeling and PAH as well as possibly other cardiovascular complications [21,22].

I suspect that the hundreds of instances of myocarditis and pericarditis investigated but then dismissed as “rare” by the FDA are the tip of the iceberg. See the FDA presentation here if it hasn't been censored already: https://www.fda.gov/media/150054/download 

One study provides an explanation of how  this might occur in their description of the circulation of the spike protein:

Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

Alana F. Ogata†1,2,3, Chi-An Cheng†1,2,3, MichaĆ«l Desjardins†3,4,5, Yasmeen Senussi1, Amy C. Sherman3,4, Megan Powell4, Lewis Novack4, Salena Von4, Xiaofang Li6, Lindsey R. Baden*3,4,6, David R. Walt*1,2,3. Downloaded from https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab465/6279075 by guest on 25 May 2021 

  

We have passed the rubicon so well described by G. Agamben, before he was censored and cancelled for challenging the governmental response to the pandemic.



No comments:

Post a Comment

Note: Only a member of this blog may post a comment.